Gender‐related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Carcinogenesis

• Publication date

  2012-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mc.20832PMID 21809392
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Melatonin and Androgen Receptor Expression Interplay Modulates Cell‐Mediated Immunity in Tropical Rodent Funambulus pennanti: An In‐Vivo and In‐Vitro Study

  2010cited by this paper
• Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines

  2009cited by this paper
• Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin

  2009cited by this paper
• Melatonin suppresses AOM/DSS-induced large bowel oncogenesis in rats.

  2009cited by this paper
• Mutual associations between malignancy, age, gender, and subsite incidence of colorectal cancer.

  2009cited by this paper
• Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro.

  2009cited by this paper
• Molecular origins of cancer: Molecular basis of colorectal cancer.

  2009cited by this paper
• Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways.

  2008cited by this paper
• Systemic and targeted therapy for advanced colon cancer

  2008cited by this paper
• Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous‐cell carcinoma

  2008cited by this paper
• Melatonin as a selective estrogen enzyme modulator.

  2008cited by this paper
• Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells.

  2007cited by this paper
• Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice.

  2007cited by this paper
• Expression of the melatonin receptor (MT) 1 in benign and malignant human bone tumors

  2007cited by this paper
• Cellular mechanisms involved in the melatonin inhibition of HT‐29 human colon cancer cell proliferation in culture

  2007cited by this paper
• Melatonin in cancer management: progress and promise.

  2006cited by this paper
• Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin.

  2006cited by this paper
• Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism

  2005cited by this paper
• Functional MT1 and MT2 melatonin receptors in mammals

  2005cited by this paper
• Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets

  2004cited by this paper
• Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis.

  2004cited by this paper
• Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation.

  2003cited by this paper
• Melatonin effects on bone: experimental facts and clinical perspectives

  2003cited by this paper
• Androgen Receptor Status in Nontumoral and Malignant Human Colorectal Tissues

  2002cited by this paper
• Gastrointestinal melatonin: localization, function, and clinical relevance.

  2002cited by this paper
• Expression of melatonin MT(1) and MT(2) receptors, and ROR alpha(1) receptor in transplantable murine Colon 38 cancer.

  2002cited by this paper
• Possible Involvement of the Nuclear RZR/ROR-Alpha Receptor in the Antitumor Action of Melatonin on Murine Colon 38 Cancer

  2002cited by this paper
• Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo.

  2002cited by this paper
• CpG hypermethylation of the promoter region inactivates the estrogen receptor‐β gene in patients with prostate carcinoma

  2001cited by this paper
• Down-regulation of mt1 melatonin receptors in rat ovary following estrogen exposure.

  2001cited by this paper
• Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.

  2001cited by this paper
• In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line

  2000cited by this paper
• Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats.

  2000cited by this paper
• Estrogen synthesis in human colon cancer epithelial cells.

  1999cited by this paper
• Melatonin content in plasma and large intestine of patients with colorectal carcinoma before and after surgery

  1999cited by this paper
• Melatonin and 2[125I]iodomelatonin binding sites in the human colon.

  1996cited by this paper
• Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand.

  1995cited by this paper
• Regional and diurnal studies of melatonin and melatonin binding sites in the duck gastro-intestinal tract.

  1995cited by this paper
• Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor.

  1995cited by this paper
• Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses.

  1994cited by this paper
• Cytosolic and nuclear androgen receptors in colorectal adenomas.

  1992cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• Cited Articles Citing Articles E-mail Alerts Estrogen Receptors a and B Are Inhibitory Modifiers of Apc- Dependent Tumorigenesis in the Proximal Colon of Min/+ Mice

  year unknowncited by this paper

• UBC4: A Repurposed Drug Regimen for Adjunctive Use During Bladder Cancer Treatment

  2025cites this paper
• THE IMPACT OF AGOMELATINE AND MELATONIN ON HUMAN COLORECTAL CANCER: AN IN VITRO INVESTIGATION

  2024cites this paper
• Melatonin alleviates aging-related heart failure through melatonin receptor 1A/B knockout in mice

  2024cites this paper
• Agomelatine, a Melatonin-Derived Drug, as a New Strategy for the Treatment of Colorectal Cancer

  2023cites this paper
• Genetic variants of glucose metabolism and exposure to smoking in African American breast cancer.

  2023cites this paper
• Modulation of the tumor microenvironment (TME) by melatonin.

  2021cites this paper
• Use of Melatonin Is Associated With Lower Risk of Colorectal Cancer in Older Adults

  2021cites this paper
• MTNR1B polymorphisms with CDKN2A and MGMT methylation status are associated with poor prognosis of colorectal cancer in Taiwan

  2021cites this paper
• Therapeutic potential of melatonin in colorectal cancer: focus on lipid metabolism and gut microbiota.

  2021cites this paper
• Genetic Signatures of Glucose Homeostasis: Synergistic Interplay With Long-Term Exposure to Cigarette Smoking in Development of Primary Colorectal Cancer Among African American Women

  2021cites this paper
• Melatonin: An important anticancer agent in colorectal cancer

  2020cites this paper
• The Relevance of Gender in Tumor-Influencing Epigenetic Traits

  2019cites this paper
• Insights on melatonin as an active pharmacological molecule in cancer prevention: what's new?

  2019cites this paper
• The correlation between PER3 rs2640908 polymorphism and colorectal Cancer in the Japanese population

  2019cites this paper
• The emergence of melatonin in oncology: Focus on colorectal cancer

  2019cites this paper
• The potential therapeutic actions of melatonin in colorectal cancer

  2019cites this paper
• Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment

  2018cites this paper
• Proinflammatory Dietary Intake is Associated with Increased Risk of Colorectal Cancer: Results of a Case-Control Study in Argentina Using a Multilevel Modeling Approach

  2018cites this paper
• Retinoic Acid Receptor-Related Orphan Receptors: Critical Roles in Tumorigenesis

  2018cites this paper
• Melatonin and Hippo Pathway: Is There Existing Cross-Talk?

  2017cites this paper
• Ramelteon, a selective MT1/MT2 receptor agonist, suppresses the proliferation and invasiveness of endometrial cancer cells

  2017cites this paper
• AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors

  2017cites this paper
• Melatonin Receptors and Their Preventive Role in Carcinogenesis

  2014cites this paper
• Melatonin regulation of biliary functions.

  2014cites this paper
• Melatonin reduces endothelin‐1 expression and secretion in colon cancer cells through the inactivation of FoxO‐1 and NF‐κβ

  2014cites this paper
• Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation

  2013cites this paper
• Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation.

  2013cites this paper
• Therapeutic actions of melatonin on gastrointestinal cancer development and progression.

  2012cites this paper
• Investigation into Early growth response 1 in colorectal disease: a study of EGR1 expression in colorectal tissue and novel protein interactions in cancer cells

  2012cites this paper